Return On Equity of Blueprint Medicines Corp from 30 Sep 2022 to 31 Mar 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Blueprint Medicines Corp quarterly and annual Return On Equity in % history and change rate from 30 Sep 2022 to 31 Mar 2025.
  • Blueprint Medicines Corp Return On Equity for the quarter ending 31 Mar 2025 was -49%, a 60% increase year-over-year.
  • Blueprint Medicines Corp annual Return On Equity for 2024 was -22%, a 89% increase from 2023.
  • Blueprint Medicines Corp annual Return On Equity for 2023 was -192%, a 139% decline from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Blueprint Medicines Corp Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q1 2025 -49% +72% +60% 01 Jan 2025 31 Mar 2025
Q4 2024 -22% +170% +89% 01 Oct 2024 31 Dec 2024
Q3 2024 -48% +106% +69% 01 Jul 2024 30 Sep 2024
Q2 2024 -85% +33% +28% 01 Apr 2024 30 Jun 2024
Q1 2024 -121% -20% -20% 01 Jan 2024 31 Mar 2024
Q4 2023 -192% -111% -139% 01 Oct 2023 31 Dec 2023
Q3 2023 -154% -65% -74% 01 Jul 2023 30 Sep 2023
Q2 2023 -118% 01 Apr 2023 30 Jun 2023
Q1 2023 -100% 01 Jan 2023 31 Mar 2023
Q4 2022 -80% 01 Oct 2022 31 Dec 2022
Q3 2022 -89% 01 Jul 2022 30 Sep 2022

Blueprint Medicines Corp Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -22% +170% +89% 01 Jan 2024 31 Dec 2024
2023 -192% -111% -139% 01 Jan 2023 31 Dec 2023
2022 -80% 01 Jan 2022 31 Dec 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.